ZEQT:CA:TSX-BMO All-Equity ETF (CAD)

ETF | Others |

Last Closing

CAD 45.46

Change

+0.40 (+0.89)%

Market Cap

CAD 0.08B

Volume

2.31K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

-0.05 (-0.28%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.02 (+0.03%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.05 (-0.23%)

CAD 3.78B
XEQT:CA iShares Core Equity Portfolio

-0.03 (-0.10%)

CAD 3.29B
PSLV-U:CA Sprott Physical Silver Trust

+0.02 (+0.22%)

CAD 3.29B
IGAF:CA IA Clarington Loomis Global Al..

+0.04 (+0.29%)

CAD 3.23B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.02 (+0.09%)

CAD 2.78B

ETFs Containing ZEQT:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.70% 77% C+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.70% 76% C+ 66% D+
Trailing 12 Months  
Capital Gain 14.02% 70% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.02% 70% C- 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.79% 77% C+ 59% D-
Dividend Return 4.79% 77% C+ 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.58% 60% D- 81% B-
Risk Adjusted Return 72.81% 95% A 92% A
Market Capitalization 0.08B 62% D 33% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike